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Introduction
If the neck is to be treated electively, there is good
evidence today that selective neck dissections are
appropriate and yield similar results as modified radical
neck dissection. As to postoperative radiotherapy after
selective dissections, however, there is less agreement.
Many surgeons would advise adjuvant radiation to any
node positive neck when less then a modified radical
neck dissection has been performed. There is general
agreement that effective treatment of the neck is in-
dicated when there is a high likelihood of occult nodal
metastases and when the neck needs to be entered for
surgical access and treatment of the primary tumour, the
patient will be unavailable for regular follow-up and also
when the status of the cervical lymph nodes cannot be
adequately assessed. When there is, however, merely
a certain likelihood of occult nodal metastases, there is
controversy on the management of the N0-neck. The
choice is then between elective treatment and watchful
waiting. This question mainly arises in the early staged
carcinomas of the anterior floor of mouth and anterior
tongue, because these usually can be excised transorally.
The rationale of elective treatment is based on the pheno-
menon that occult disease in the neck will inevitably
develop into clinically manifest disease and that despite
regular follow-up some patients will develop inoperable
disease in the neck with a wait and see policy. Untreated
occult disease in the neck may also give rise to distant
metastases, while the lymph node is growing into clinically
detectable size. Conversely there are arguments against
elective treatment. First, it entails overtreatment of the
majority of patients, Second, it means increased mor-
bidity, especially when performed bilaterally. Third, it
involves increased operating time and costs. It has
also been argued that removing lymph node barriers
and changing patterns of spread could influence prognosis
in case of local recurrence or second primary tumour.
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Adequate management of the clinically negative neck is vital and should be balanced between over and undertreatment.
Compared to clinical examination ultrasound-guided fine-needle aspiration cytology (USgFNAC) at initial staging can
reduce the risk of occult metastases for T1-T2 squamous cell carcinoma of the oral cavity or oropharynx considerably to 20%,
which justifies local excision of the tumour and a wait-and-see policy for the neck. SN identification and aspiration did not
decrease the false-negative rate, and we have therefore abandoned its use in this setting. Using USgFNAC for follow-up enabled
early detection of a significant percentage of neck failures and a high salvage rate with therapeutic neck dissection of 80%.
Detecting subclinical neck metastases continues to challenge clinicians and debate continues.
Uk∏ad ch∏onny szyi klinicznie wolny od przerzutów – co robiç?
Odpowiednie post´powanie w przypadku, gdy w´z∏y ch∏onne szyi sà klinicznie wolne od przerzutów, musi byç bardzo
wywa˝one. W przypadku raka p∏askonab∏onkowego jamy ustnej i gard∏a biopsja cienkoig∏owa pod kontrolà USG pozwala na
dok∏adnà ocen´ w´z∏ów ch∏onnych i potwierdzenie do 80% przypadków subklinicznych przerzutowych w´z∏ów ch∏onnych. W
przypadku uk∏adu ch∏onnego szyi taki wynik usprawiedliwia decyzj´ o miejscowym usuni´ciu guza i dalszej obserwacji
chorego ("wait and see policy"). OkreÊlanie w´z∏ów wartowniczych (wraz z biopsjà cienkoig∏owà) nie poprawi∏o odsetka
wyników fa∏szywie ujemnych, odstàpiliÊmy zatem od stosowania tej metody. Biopsja cienkoig∏owa pod kontrolà USG
pozwoli∏a na wczesne wykrycie znacznego odsetka wznów w´z∏owych i na zwi´kszenie skutecznoÊci ratujàcych operacji
usuni´cia uk∏adu ch∏onnego szyi do 80%. Diagnostyka subklinicznych przerzutów do w´z∏ów ch∏onnych szyi nadal jednak
stanowi ogromny problem i rodzi wiele kontrowersji.
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The prognostic impact of a wait and see-policy in
case of clinically undetectable disease in early staged oral
squamous cell carcinoma has been the topic in many
studies, but only three of these studies were prospective.
Vandenbrouck et al. found no significant difference in
outcome between patients whose neck was treated
electively and those whose neck was closely observed [1].
They concluded that in squamous cell carcinoma of the
oral cavity staged T1-3N0, it seems possible, without risk,
to delay neck dissection until a node is detectable,
although it is reasonable to perform elective neck
dissection in those cases in which the patient is una-
vailable for regular follow-up. A similar study was
performed by Fakih et al. and by Kligerman et al., but
these trials also failed to show survival benefit of elective
neck dissection in early stage oral cancer above a wait-
and-see policy [2, 3]. All three described relatively small
numbers of patient groups, and none used an imaging
modality for initial selection of patients or for follow-up
after wait-and-see policy was performed. A proper
randomised clinical trial will never be carried out because
of the very large number of patients needed to allow for
meaningful conclusions.
Therefore a practical approach is adopted towards
the N0 neck. Elective treatment is performed if the risk of
occult metastases exceeds 20% or in case the neck is
entered for technical reasons. Conversely, a wait-and-see
policy is justified if the risk of occult metastases is below
20% and if strict follow-up can be ensured. Weiss et al.
performed a decision analysis study based on literature
data on prognosis and outcome and substantiated this
"acceptable" risk of occult metastases [4]. When
assessment of the status of neck nodes is carried out by
means of palpation alone, most sites and stages of
squamous cell carcinoma of the head and neck, including
early stage oral cavity tumours, qualify for elective
treatment on this basis.
Imaging
The question arises if imaging techniques can sufficiently
reduce the occult metastasis rate in certain risk groups to
allow for watchful waiting. Although both computed
tomography (CT) and magnetic resonance imaging
(MRI) of the neck have been found to be superior to
palpation in detecting cervical metastases, these
modalities still have a relatively low accuracy for the N0
neck [5-7]. In contrast, ultrasound-guided fine-needle
aspiration cytology (USgFNAC) has a higher sensitivity
and specificity and is more cost-effective than CT and
MRI (Figure 1) [5]. It can also be repeated easily during
follow-up. In experienced hands, sensitivity for N0 neck
can reach 73% with a specificity of 100%, although others
reported sensitivities in the range of 42% to 50% [5, 6, 8,
9]. In general two major points have to be taken into
account in decision making towards management of the
clinically negative neck: the risk of occult neck metastases
and the prognostic impact of wait-and-see policy. This
last issue depends on delay of treatment since prognosis is
related to number, size and level of metastases, extranodal
spread and to distant metastasis. USgFNAC might be
able to decrease the delay treatment in case occult
metastatic nodes are present and thus increase salvage
rate of subsequent neck metastasis. The literature quotes
salvage rates of 28-59 % by using clinical examination
alone [2, 10-12]. Using a policy of strict preoperative
examination by USgFNAC Kaneko et al., recently
performed a decision and sensitivity analysis in patients
with cancer of the oral cavity without clinical nodal
metastases [13]. They calculated the probabilities of
subclinical nodal metastases and 5-year survival using
registry data. Parameters included complete nodal
metastases resection rate and a utility rating that describes
the health state induced by dissection compared with the
situation in a careful observation group. Their results
showed that elective neck dissection must guarantee
a complete resection of subclinical nodal metastases with
no disadvantage to heath state to be evaluated as equally
satisfactory as careful observation. Since especially this
last premise is unrealistic they concluded that observation
of the neck is preferable in the light of strict pretreatment
and follow-up examinations by USgFNAC.
Outcome of a wait-and-see policy using USgFNAC
We recently performed an analysis of clinical outcome
of our policy in terms of neck failures and salvage rates
after therapeutic neck treatment [14]. The study group
Figure 1. Ultrasound guided fine needle aspiration cytology of enlarged lymph nodes in the neck
consisted of 161 previously untreated patients (82 men, 79
women; mean age 62 years) with a T1-2N0 histologically
proven SCC of the oral cavity or oropharynx from 1993-
2000. All patients were treated with transoral excision of
the primary tumour on the basis of negative USgFNAC
findings at initial staging. USgFNAC of suspected lymph
nodes was performed based on size criteria. Patients
received strict follow-up of the neck, including USgFNAC
every 3 months for the first 2 years. No patient in this
series received postoperative radiotherapy on the basis of
adverse findings in the primary tumour. Thirty-four
patients (21%) developed a delayed neck metastases
without local recurrence (33 ipsilateral, 1 contralateral).
Thirty of these occurred in the first year following
treatment and only 4 in de second year. All neck
recurrences were treated by neck dissection and 31 also
received postoperative radiation therapy. A total of 27
(79%) remained disease free and 7 died of their disease,
including 4 regional recurrences in the treated neck (one
also had distant metastasis), 2 contralateral recurrences
in the non-dissected neck (one also had distant meta-
stasis) and one patient with distant metastases.
This study shows that USgFNAC is both able to
reduce the neck recurrence rate after observation from an
estimated risk of 40% to 21% and to increase neck
salvage rate from an average rate of 52% in the literature
to 79% (Table I) [1-3, 10, 12, 14-16].
Table I. Outcome in patients with a clinically N0 neck 
in whom a wait-and-see policy was conducted
Author No. Neck Recurrences Salvaged
Vandenbrouck et al. [1] 36 17 (47%) 14 (82%)
Cunningham et al.[15] 43 18 (42%) 9 (50%)
Fakih et al. [2] 40 23 (57%) 7 (30%)
Khafif et al. [16] 396 90-95 (24%) 53 (59%)
Ho et al. [10] 28 10 (36%) 3 (30%)
Kligerman et al. [5] 33 11 (33%) 3 (27%)
McGuirt et al. [12] 103 37 (36%) 22 (59%)
Total 679 213 (32%) 111 (52%)
Nieuwenhuis et al. [14] 161 34 (21%) 27 (79%)
Is it possible to improve the early detection rate of
occult lymph node metastasis by USgFNAC even further?
The possible causes of false-negative results are aspiration
of the wrong node or aspiration at the wrong part of
a node that contains only a small metastasis (sampling
error), and false interpretation of the cytological slides.
The selection of lymph nodes for aspiration is currently
based on known patterns of lymphatic spread and par-
ticularly on size criteria. However, the number of nodes in
the neck is large, and the patterns of spread are not
always consistent. Sensitivity of USgFNAC might be
improved by a more functional selection of the lymph
node(s) at highest risk of harbouring occult metastases,
i.e., most notably the sentinel node (SN).
Sentinel node concept
The SN concept is based on the orderly progression of
tumour cells within the lymphatic system. Metastasis to
lymph nodes is not a random event and can be deter-
mined by identifying the lymph flow from the tumour
site to the first draining lymph node. In theory, the SN will
thus be the first node to contain metastases and
examination of this node should predict accurately
regional lymph node status. In a pilot study we have
evaluated the feasibility of the combined use of SN
lymphoscintigraphy and USgFNAC [12]. Our initial
experience in 12 patients showed that lymphoscintigraphic
identification and subsequent aspiration of SNs was
a feasible technique in patients with a squamous cell
carcinoma of the oral cavity or oropharynx with a N0
neck. On the basis of these results, we decided to
investigate whether the combined use of lymphoscin-
tigraphy and SN-USgFNAC could decrease the false-
negative rate in a larger group of patients compared with
our former USgFNAC policy of enlarged lymph nodes
only [14]. This group consisted 39 patients with a T1-2N0
oral/oropharyngeal SCC staged with additional SN
aspiration (SN-USgFNAC) after USgFNAC was negative.
Three to four submucosal peritumoural injections of 15-
20 MBq 99mTc-labeled colloidal albumin suspended in 0.4
ml saline (Nanocoll) were administered. Within 2 minutes
after injection, lateral dynamic lymphoscintigraphic
images were obtained (20 × 60 sec acquisitions) with the
patient in supine position under a gamma camera with
a low-energy high-resolution parallel-hole collimator.
Subsequently, static scintigraphy was performed during
120 sec in anterior projection to reduce superimposition
caused by radioactive scatter originating from the
injection site over the SNs. After visualization of the
SN(s), the position was marked on the overlying skin with
the use of a point-of-source 57Co marker and confirmed
with a 14-mm diameter handheld gamma probe. From
nine patients additional static images were acquired 2 to
4 hours after injection. SNs were defined as all lymph
nodes visible in 20-min dynamic scintigraphy or visualiza-
tion by additional static images after 2 to 4 hours after
injection. Subsequently, USgFNAC was performed of the
visualized SNs and the enlarged lymph nodes. After
preparation of the cytologic smears, the needle and
syringe were washed in phosphate-buffered saline to
obtain residues that were used for radioactivity counting
in a gamma counter. In 35 of 39 (90%) patients, at least
one SN was visualized by. One SN was visible in 20
patients, two SNs in 14 patients, and 1 patient showed
three SNs after 20-min dynamic imaging. All SNs were
located ipsilateral. In total, 51 SNs were identified
scintigraphically, which were located in level I in 20 cases,
in level II in 22 cases, in level III in 8 cases, and in level IV
in 1 case. Confirmation of the SN position with the
handheld gamma probe proved to be reliable if the SN
was located in levels II through IV. In four patients with
primary tumours in the anterior oral cavity, dynamic
scintigraphy did not enable identification of a SN
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independent of the injection site, probably because of
radioactive scatter originating from the primary tumour.
However, in three of these four patients, the SN could be
identified afterward by measurement of radioactivity in at
least one of the aspirated residues of enlarged lymph
nodes. Hence, in only 1 of 39 patients we did not succeed
in identifying a SN. In nine patients static images were
acquired 2 to 4 hours after injection, which showed
additional hot spots in four patients. In 10 of the 38
patients, 13 lymph nodes would not have been selected for
aspiration on the basis of the size criteria. From this
group, 11 lymph nodes of 9 patients were aspirated. The
minimal diameters of these SNs varied from 1.6 mm to
3.8 mm. From 2 of these 11 SNs insufficient material was
aspirated for a cytologic diagnosis, both with a minimal
diameter of 1.6 mm. From the other 9 SNs with minimal
diameters ranging from 1.9 mm to 3.8 mm, diagnostic
smears were obtained; these were all tumour cell-negative
at cytologic diagnosis.
During follow-up, 10 of these 39 patients (26%)
developed a lymph node metastasis in the neck within
1.5 to 8 months after treatment of the primary tumour.
All but two patients developed metastases in levels of
the neck, which corresponded to those of the SNs
identified at the initial staging. One of these two patients
developed a lymph node metastasis on the contralateral
side. These 10 patients all underwent therapeutic neck
dissection, and 9 also received postoperative radiotherapy
based on histopathologic findings. The sentinel node
procedure is therefore not capable of improving the
detection rate of occult nodal metastases by USgFNAC in
head and neck cancer patients. Therefore we concluded
the most likely cause of false-negative USgFNAC is
aspiration of the wrong part of a node containing a very
small metastasis
Micrometastasis
Conventional histopathology, serial sectioning,
immunostaining and molecular analysis are increasingly
sensitive in finding tumour cells (or tumour DNA) in
lymph nodes. Van den Brekel et al. have used meticulous
serial sectioning of 96 electively dissected neck specimen
of 79 patients [18]. Nodes were sectioned every 3-4 mm
and conventionally stained with Hematoxilin & Eosin.
Tumour positive specimen containing only micro-
metastases of 3 mm or less in dimension were found in
9 out of 36 cases (25%). This finding was later confirmed
by immunohistochemistry-based techniques [19]. Current
research focuses on using additional techniques, e.g., by
using conjugates of monoclonal antibodies with
radionuclides (particularly positron emitters).
Conclusions
USgFNAC at initial staging can reduce the risk of occult
metastases for T1-T2 squamous cell carcinoma of the oral
cavity or oropharynx considerably, which justifies local
excision of the tumour and a wait-and-see policy for the
neck. SN identification and aspiration did not decrease
the false-negative rate, and we have therefore abandoned
its use in this setting. Using USgFNAC for follow-up
enables early detection of a significant percentage of neck
failures and a high salvage rate with therapeutic neck
dissection.
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